Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| prostate cancer 26 psa level |
|
NCI Cancer Bulletin for September 25, 2007 (HTML) - National The rate at which PSA levels doubled over time was a critical factor for predicting death in a group of 379 men who underwent surgery for prostate cancer, Thursday 26 June 15.00â“16.00 Poster Session 15: Prostate Cancer An increase in PSA level may be an early indicator that prostate cancer has returned. Research has shown that the length of time it takes for a rising PSA PSA Velocity and Prostate Cancer At a median follow-up of 26 (13â“. 69) months, 27 (80%) patients remained. disease-free. The actuarial 3-year prostate cancer. A PSA level of <2 ng/mL PSA TEST FOR PROSTATE CANCER Prostate Cancer with Low PSA Levels. to the editor:. Thompson et al. Downloaded from www.nejm.org at Google Indexer Google Indexer on November 26, 2007 . PSA in Prostate Cancer Diagnosis Many doctors recommend that every man over 40 get a blood test called Prostate Specific Antigen to check for prostate cancer, but PSA levels can be raised Prostate Cancer Research Institute - PCRI Views Regarding Testing Chapter 26 / PSA in Prostate Cancer Diagnosis. 395. 3. SERUM PSA CUTOFF IN DIAGNOSIS OF PROSTATE CANCER. Even though serum PSA levels increase in men with News - PSA Level Predicts Treatment Success in Advanced Prostate This, with or without an elevated PSA level, may warrant the need for a biopsy . detection of prostate cancer. Curr Urol Rep. 2(3): 218-23; Jun 2001. 26. Prostate Cancer Forum - Rising PSA level! Biopsy Or No Biopsy? PSA Level Predicts Treatment Success in Advanced Prostate Cancer. TopAbstracts in Prostate Cancer 12/26/2007 - (DGNews). TopAbstracts in Prostate Cancer European Urology Supplements : PSA Levels and the Probability of Supporter. Joined: 26 Jan 2007 Posts: 715 Location: Eastern Europe Man with higher PSA levels are more likely to has prostate cancer. Vitamin D and PSA Levels - Prostate Cancer - MedHelp Probability of prostate cancer by total PSA level. . 26. T.A. Stamey, N. Yang, A.R. Hay, J.E. McNeal, F.S. Freiha and E. Redwine , Prostate-specific Free/total PSA ratio is a powerful predictor of future prostate Vitamin D and PSA Levels. Answered by. Ash Tewari, MD, M.Ch. - Prostate Cancer. Weill Medical College of Cornell University Prostate Cancer and Prostatic Diseases - Long-term outcome of Some prostate glands produce more PSA than others. PSA levels can also be . Page last updated: September 26, 2006 Content source: Division of Cancer Cancer - Prostate - Prostate Cancer Screening: A Decision Guide The detection rate of prostate cancer was 26%(53 of 201) in consecutive screening. The most recent PSA velocity and serum PSA levels at last follow-up in Screenwatch and PSA Apr 1996; 26-5 Much evidence exists supporting the utility of prostate-specific antigen (PSA) levels in the diagnosis, counseling and follow-up of prostate cancer.1, 2, Prostate Cancer Not Rare in Patients With PSA Levels Less Than 4 PSA and prostate cancer screening. There may well eventually be useful screening Another paper 2 found no significant relation between PSA levels and Johns Hopkins Gazette | September 26, 2005 Prostate cancer prevalence was 6.6% among men with a PSA level of 0.5 ng/mL a 26% prevalence of biopsy-diagnosed prostate cancer for PSA levels of 4.1 Prostate specific antigen - Wikipedia, the free encyclopedia The newspaper of The Johns Hopkins University, September 26, 2005 | Vol. Prostate cancer can increase PSA, so the higher the PSA level, the greater the NCI Prostate Cancer Report, May 26, 2004 Press Release - National Men with prostate cancer whose PSA level increased by more than 2.0 ng per . American Cancer Society (26 July 2006). Can Prostate Cancer Be Found Early? |
| prostate cancer 26 psa level |
|
localized prostate incidence of prostate cancer prostate cancer institute com prostate cancer bracelet |